v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (126,887) $ (169,793)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 18,219 17,100
Depreciation and amortization 1,710 1,715
Operating lease, right-of-use-asset amortization 417 376
Finance lease, right-of-use-asset amortization 1,214 1,214
Net amortization of premiums and discounts on short-term investments 97 (2,098)
Impairment on property, plant and equipment 642 0
Noncash interest expense 1,461 829
Unrealized foreign currency transaction (gains) losses (621) (284)
Changes in operating assets and liabilities:    
Research and development incentives receivable 1,114 1,264
Increase in inventories (9,867) 0
Prepaid expenses and other current assets 2,278 94
Other non-current assets 0 0
Accounts payable (695) (5,165)
Accrued expenses and other current liabilities (12,068) (2,766)
Operating lease liabilities (444) (398)
Other non-current liabilities 0 (316)
Net cash used in operating activities (123,430) (158,228)
Cash flows from investing activities:    
Purchases of property, plant and equipment and software capitalization (83) (4,083)
Proceeds from sales of property, plant and equipment 80 0
Purchase of short-term investments (9,884) (47,430)
Proceeds from sales and maturities of short-term investments 69,643 200,730
Net cash provided by investing activities 59,756 149,217
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of underwriting fees and discounts 109,980 0
Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and offering costs 31,020 0
Proceeds from long term debt 15,000 0
Principal payment of finance lease obligation (416) (343)
Proceeds from exercise of stock options 5,765 509
Net cash provided by financing activities 161,349 166
Effect of exchange rate changes on cash, cash equivalents and restricted cash 1,134 26
Net increase (decrease) in cash, cash equivalents and restricted cash 98,809 (8,819)
Cash, cash equivalents and restricted cash at beginning of period 210,727 112,822
Cash, cash equivalents and restricted cash at end of period 309,536 104,003
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 3,565 2,134
Cash paid for income taxes, net 66 0
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment included in accounts payable and accrued expenses $ 158 $ 177